Regulation of SETD2, a histone methyltransferase, in advanced clear cell renal cell carcinoma (ccRCC).

被引：0
|
作者：
Thai Huu Ho
Monzon, Federico A.
Anh Hoang
Tamboli, Pheroze
Furge, Kyle A.
Dykema, Karl
Petillo, David
Teh, Bin Tean
Tannir, Nizar M.
Mien-Chie Hung
Jonasch, Eric
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Methodist Hosp, Res Inst, Houston, TX 77030 USA
[3] Van Andel Res Inst, Grand Rapids, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
D O I：
10.1200/jco.2012.30.5_suppl.368
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
368
引用
收藏
页数：1
相关论文
共 50 条
  • [1] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, T. H.
    Monzon, F. A.
    Hoang, A.
    Hung, M. C.
    Jonasch, E.
    BJU INTERNATIONAL, 2012, 109 : 1 - 2
  • [2] SETD2, a histone methyltransferase, is misregulated in advanced clear cell renal cell carcinoma (ccRCC)
    Ho, Thai H.
    Monzon, Federico A.
    Anh Hoang
    Tamboli, Pheroze
    Furge, Kyle
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar
    Jonasch, Eric
    Hung, Mien-Chie
    CANCER RESEARCH, 2012, 72
  • [3] Molecular characterization of SETD2, a histone methyltransferase, in clear cell renal cell carcinoma (ccRCC)
    Thai Huu Ho
    Monzon, Federico A.
    Hoang, Anh
    Tamboli, Pheroze
    Furge, Kyle A.
    Dykema, Karl
    Petillo, David
    Teh, Bin Tean
    Tannir, Nizar M.
    Hung, Mien-Chie
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [4] Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
    Yu, Mengxue
    Qian, Kaiyu
    Wang, Gang
    Xiao, Yu
    Zhu, Yuan
    Ju, Lingao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [5] Histone Methyltransferase Gene SETD2 Is a Novel Tumor Suppressor Gene in Clear Cell Renal Cell Carcinoma
    Duns, Gerben
    van den Berg, Eva
    van Duivenbode, Inge
    Osinga, Jan
    Hollema, Harry
    Hofstra, Robert M. W.
    Kok, Klaas
    CANCER RESEARCH, 2010, 70 (11) : 4287 - 4291
  • [6] Prognostic Impact of Loss of SETD2 in Clear Cell Renal Cell Carcinoma
    Santos, Victor Espinheira
    da Costa, Walter Henriques
    Bezerra, Stephania Martins
    da Cunha, Isabela Werneck
    Caon Nobre, Jayme Quirino
    Brazao Jr, Eder Silveira
    Meduna, Rafael Ribeiro
    Rocha, Mauricio Murce
    Fornazieri, Lucas
    Zequi, Stenio de Cassio
    CLINICAL GENITOURINARY CANCER, 2021, 19 (04) : 339 - 345
  • [7] The histone methyltransferase SETD2 negatively regulates cell size
    Molenaar, Thom M.
    Malik, Muddassir
    Silva, Joana
    Liu, Ning Qing
    Haarhuis, Judith H., I
    Ambrosi, Christina
    Kwesi-Maliepaard, Eliza Mari
    van Welsem, Tibor
    Baubec, Tuncay
    Faller, William J.
    van Leeuwen, Fred
    JOURNAL OF CELL SCIENCE, 2022, 135 (19)
  • [8] The consequence of SETD2 mutation in clear cell renal cell carcinoma progenitor cells
    Li, J.
    Osinga, J.
    Ferronika, P.
    Van Werkhoven, M. B.
    Terpstra, M. M.
    Van der Vlies, P.
    Duns, G.
    Westers, H.
    Sijmons, R. H.
    Kok, K.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S109 - S109
  • [9] Synthetic lethal interaction between SETD2 loss and inhibition of PI3Kβ in clear cell renal cell carcinoma (ccRCC)
    Terzo, Esteban
    Chiang, Yun C.
    Chytil, Anna
    Jansen, Valerie M.
    Rathmell, Kimryn
    CANCER RESEARCH, 2018, 78 (13)
  • [10] The effect of loss of SETD2 on mitochondria! dysfunction in clear cell renal cell carcinoma.
    Hapke, Robert
    Beckermann, Katy
    Rathmell, Kimryn
    Haake, Scott Mattox
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
12345